• Approximately 20-25% of adults with Type 1 diabetes have impaired awareness of hypoglycaemia (IAH), which is associated with a six-fold higher risk of severe hypoglycaemia. Existing measures of impaired awareness of hypoglycaemia have acknowledged limitations.
Introduction
Approximately 20-25% of adults with Type 1 diabetes have impaired awareness of hypoglycaemia (IAH) [1] ; after 25 years almost 50% are affected [2] and the risk of severe hypoglycaemia (SH) is sixfold higher [1, 3] . IAH may compromise activities such as driving, and glycaemic targets may need to be modified to avoid SH [4, 5] . While significant impairment can debar affected individuals from driving, neither a
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definition of IAH nor how it should be assessed are described in the European Union licensing regulations [6] . An accurate, reliable and validated method to characterize problematic hypoglycaemia (frequency, severity, impact and impaired awareness), is needed to inform compilation of medical reports for driving licensing authorities.
Current methods for identifying IAH involve use of the self-report measures the Gold score [3] and the Clarke questionnaire [7] , separately or in combination [8] . The Gold score is brief (a single question with a seven-point response scale) with good face validity but it enables identification only and does not facilitate detailed characterization of IAH. The Clarke questionnaire [7] comprises eight questions documenting exposure to hypoglycaemia and a subjective estimation of the glycaemic threshold for symptom generation. It provides a detailed assessment but has limitations: the SH definition is not that of the American Diabetes Association Hypoglycaemia Workgroup [9] ; consensus for the glycaemic thresholds used is lacking; the recall periods are inconsistent between questions and with the time periods used in most clinical trials; and most notably, nocturnal hypoglycaemic events are not captured.
Although the Gold score and Clarke questionnaire have good concordance in detecting IAH, they share a limited ability to characterize or evaluate the severity of IAH and lack some sensitivity to change [8] .
Our aim was to design and conduct preliminary psychometric validation of a novel, optimized measure for detailed characterization of problematic hypoglycaemia, including frequency, severity, impact and onset awareness: the Hypoglycaemia Awareness Questionnaire (HypoA-Q).
Patients and methods

Study 1: design and debriefing of the Hypoglycaemia Awareness Questionnaire
The design of the HypoA-Q was rigorous and iterative, involving multiple interviews with adults with Type 1 diabetes who were experiencing problematic hypoglycaemia. After every two to three interviews, diabetologists and psychologists discussed findings, and questionnaire items were refined.
Interviews continued until an optimized design was achieved (10 th draft) with no further concerns being raised. Full study details are provided in Appendix S1. 
Study measures
In addition to the newly developed HypoA-Q (described in the Results section), the questionnaire booklet included:
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• Gold score [3] : a score of ≥4 designates IAH.
• The Guy's and St Thomas' Minimally Modified Clarke Hypoglycaemia Survey, derived from the Clarke questionnaire [7] : a score of ≥4 designates IAH.
• Problem Areas in Diabetes (PAID) scale [10] : the total score, derived from this 20-item measure, ranges from 0 to 100, with higher scores indicating greater diabetes distress [11] .
Statistical analysis
The scoring on the HypoA-Q was determined using a combination of statistics to yield a profile measure,
i.e. several item and subscale scores. Exploratory factor analysis was conducted on 17 items (5a-d; 6a-c; 7-13; 17-19) considered suitable for profiling IAH (including symptoms whether awake or asleep).
Notably, questions about previous experience of SH were excluded from the impaired awareness subscale explorations, on the basis that SH is a consequence of IAH and should not be part of its definition. Factor loadings ≥0.3 and ≥0.6 were considered meaningful and high, respectively [12] . To support internal consistency reliability, Cronbach's α of ≥0.70 was considered satisfactory [13] . Sixteen items were considered conceptually distinct, relating to reporting of hypoglycaemic events (frequency and severity) and related healthcare utilization (items 1, 2a-d), while awake (items 3, 4a-d), and while asleep (items 15, 16a-e). These were scored separately and analysed individually providing descriptive statistics of frequency, severity and impact of hypoglycaemia. Two open-ended questions (items 14 and 20) invited qualitative responses.
Statistical analyses were conducted using IBM SPSS for Windows version 21 (Chicago, IL, USA).
Descriptive statistics are shown as number (percentage) and mean ± SD unless otherwise indicated. All statistical tests were conducted using non-parametric statistics because distributions of several variables were skewed. Missing data were considered 'missing completely at random'.
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Frequency analyses were conducted to examine HypoA-Q completion rates and response ranges. High overall completion rates (>95%) were taken as evidence of the questionnaire's acceptability. Variables with near-significant correlations (P<0.20) were block-entered into the regression models [14] .
Models were generated to include the Gold score (where P<0.20) and either Clarke score (model A) or
HypoA-Q (model B), to provide an indication of the extent to which the HypoA-Q may add value over existing measures of IAH. It should be noted that questions 3 and 4 on the Clarke questionnaire ask about SH in the preceding 6 months and year, respectively, and are included in the Clarke composite score, artificially inflating any relationship with self-reported SH.
Results
Study 1: design and debriefing of the Hypoglycaemia Awareness Questionnaire
The 17 participants [nine women (53%)] were aged 48±10 years, with a mean ± SD Type 1 diabetes duration of 28±12 years and HbA 1c concentration of 62±11 mmol/mol (7.8±1.0%). All had experienced IAH previously but did not necessarily have IAH at time of assessment. Eight (47%) used multiple daily injections and nine (53%) used continuous subcutaneous insulin infusion (insulin pump therapy).
The themes and issues raised by patients, that informed the content of our draft items, are summarized using verbatim quotes in Table 1 . Further results are provided in Appendix S1. The questionnaire (Appendix S2) includes 33 items, plus two free-text items, assessing:
• recall of hypoglycaemia, including mild (self-treated) and severe events (requiring assistance for recovery);
• healthcare utilization related to SH (i.e. paramedic attendance, treatment in casualty department or hospital admission);
• blood glucose thresholds at which symptoms commence and the nature of symptoms generated at those thresholds;
• perceived awareness of symptoms;
• perceived diminished awareness;
• frequency of capillary blood glucose monitoring when 'feeling low'.
Separate questions enquire about hypoglycaemia while awake and asleep.
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Study 2: psychometric validation of the Hypoglycaemia Awareness Questionnaire
Participant characteristics
Of the 141 clinic attendees approached, 120 (85%) participated, of whom 53 (44%) were women. Their mean ± SD age was 44±16 years, Type 1 diabetes duration was 22±13 years and HbA 1c concentration 66±14 mmol/mol (8.2±1.3%). Of the 21 non-participants, 10 agreed but did not return the questionnaire, nine gave no reason for non-participation, one had a conflicting appointment and one was unable to complete the questionnaire because of SH. Of the 21, nine (43%) were women. Their mean ± SD age was 52±11 years and Type 1 diabetes duration 27±15 years. Eleven (52%) had a clinical diagnosis of IAH.
Acceptability
Completion rates were ≥95% for 20 of the 33 items, ≥90% for another 11 and ≥80% for the remaining two. One third of participants wrote comments in the free-text boxes (items 14 and 20). Comments included details of idiosyncratic symptomatology, typical circumstances surrounding hypoglycaemia onset and information to clarify responses to other items. No issues warranted the design of additional items.
Scale structure and internal consistency reliability
Factor loadings and internal consistency reliability are shown in Table 2 . Three subscales were identified, with total scores for each derived by summating item scores (with higher scores indicating greater impairment of awareness):
• impaired awareness (items 7, 8, 10, 11 and 12);
• symptom level (items 6a, b and c), reflecting blood glucose thresholds at which autonomic, neuroglycopenic and non-specific (malaise) symptoms of hypoglycaemia [15] are experienced;
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• symptom frequency (items 5a, b, c and d), detailing symptoms associated with differing levels of blood glucose (<2.5; 2.5-2.9; 3.0-3.4; 3.5-3.9 mmol/l).
Items 9, 13 and 17-19 did not load on these factors and were treated as separate items for scoring purposes. The hypoglycaemia while asleep items (17-19) describe a qualitatively different experience and the latter two include a 'not applicable' response option.
Frequency of hypoglycaemia events and healthcare utilization
In the preceding week, 73% of participants (86/118) reported having one or more hypoglycaemic event (mild or severe, when awake or asleep), with 18% (21/118) reporting three or more events, while 20%
(23/115) experienced at least one SH event in the preceding 6months. A total of 62 SH events were reported by this group (mean ± SD 2.7 ± 3.1 events per person with SH), of which 12 events (19%) required paramedic attendance and one resulted in transfer and admission to hospital.
During the preceding 6 months, 94% of participants (111/118) had experienced at least one hypoglycaemic event (mild or severe) while awake; 72% (85/118) reported three or more events, and 33% (39/118) reported experiencing hypoglycaemia at least once a week. A total of 21% (23/109) had experienced SH while awake.
During the preceding 6 months, hypoglycaemia while asleep (predominantly nocturnal hypoglycaemia)
was reported by 64% of participants (75/117). A total of 41% (48/117) had experienced episodes less than once a month, while 10% (12/117) reported hypoglycaemia while asleep at least weekly and 28%
(32/116) had experienced at least one SH event while asleep. Of those, 21 had experienced events where they had been given glucose orally, 12 had required glucagon by injection, two had experienced a
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'major problem' (defined as, e.g. a fit, tongue biting, fall, collapse or incontinence). A total of 27 participants had experienced episodes where they did not wake and only realised afterwards that they had experienced a hypoglycaemic event.
Convergent and divergent validity
Satisfactory convergent validity was demonstrated by highly significant inter-scale correlations between 
Known-groups validity
The impaired awareness subscale discriminated, as expected, between those with and without known IAH, according to the Gold score (10.80±3.42 vs 5.09±3.20; P<0.001), although symptom level and symptom frequency did not differentiate. Findings were similar when the Clarke questionnaire was used to identify IAH (data not shown). As expected, HypoA-Q items that focused on the frequency of SH events (items 2a, 4b, 4c) also showed expected differences between those with and without IAH ( Table   3 ). As expected, items that focused on experience of mild hypoglycaemia did not discriminate between those with and without known IAH.
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Predictive validity
The HypoA-Q subscales and individual items contributed significantly to a model explaining the presence of SH events in the preceding 6 months (Table 4) 
Discussion
The HypoA-Q fulfils the need for a contemporary, comprehensive assessment of IAH, to improve characterization of IAH when awake and asleep. HypoA-Q items also enable systematic characterization of frequency and severity of recent hypoglycaemia, including SH-related healthcare utilization.
A comprehensive, iterative design study generated a detailed profile measure and has shown that the questionnaire has good breadth of content, face and content validity. The preliminary psychometric validation study showed satisfactory scale structure and internal consistency reliability. Convergent
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This article is protected by copyright. All rights reserved. Table 3 ). Indeed, the former scored almost two standard deviations higher than the latter on the impaired awareness subscale, equivalent to a very large effect size [20] . While it is too soon to determine a clinically important cut-off point for impaired awareness, which would require longitudinal data and multiple datasets, this sensitivity to between-group differences is certainly promising.
The lack of relationships between the symptom level and symptom frequency subscales and other variables raises uncertainty about their discriminatory properties and responsiveness; however, it was clear in the questionnaire design phase that such subscales added a qualitatively distinct method of assessing IAH, which may be useful in routine clinical practice and merits further exploration.
Logistical regression analyses showed that including the HypoA-Q variables in models of severe hypoglycaemia and hypoglycaemia while asleep provided greater explanatory power than including the Gold score or Clarke questionnaire alone. The impaired awareness subscale score and item 13 (being 'more aware [in the past 6 months] of my hypos coming on than I used to be') were associated significantly with severe hypoglycaemia (Table 4 ; model 1B), suggesting that they may have predictive validity. Item 9 'check blood glucose if I feel low' is likely to be important in the context of those whose awareness may not be adequate for driving, although many other behavioural factors determine driving risk. While these findings suggest that HypoA-Q is likely to have predictive validity and to be responsive,
this needs to be tested fully in a prospective study. The HypoA-Q has been used in the HypoCOMPaSS trial [17] , with recently documented evidence of its responsiveness to intervention to improve awareness of hypoglycaemia [18] .
The HypoA-Q includes items about awareness and hypoglycaemia while asleep, which is not addressed by the Gold score or Clarke questionnaire. While the latter were not associated with hypoglycaemia while asleep (Table 4 ; model 2A), item 13 (being 'more aware [in the past 6 months] of my hypos coming on than I used to be') and item 9 ('symptoms wake me') were both associated with hypoglycaemia while asleep (Table 4 ; model 2B). While this information can be gleaned in a clinical interview, the use of systematic and comprehensive questioning should be encouraged in clinical and research settings, and the HypoA-Q is designed to facilitate this.
Although it takes <7 min to complete, the HypoA-Q was never intended to match the simplicity or brevity of the single-item Gold score [3] . Feedback from design study participants indicated they considered a single-page questionnaire neither feasible nor desirable. Paradoxically, they found the longer questionnaire more acceptable and easier to complete than the initial shorter draft.
A key strength of Study 1 is the rigour with which the questionnaire was designed and debriefed.
Questionnaire design took account of existing knowledge of problematic hypoglycaemia, IAH syndrome and its pathogenesis. It benefited from broad, in-depth consultation, which continued until all issues were resolved. Patients with Type 1 diabetes were selected purposefully for their experience of hypoglycaemia and IAH, rather than to represent all adults with the condition, but it is important to acknowledge that such experience means this was a relatively homogeneous group. A strength of Study 2 (psychometric validation) is that data were collected in a routine clinical setting, offering opportunity to assess HypoA-Q suitability in a broad cross-section of adults with Type 1 diabetes (half with clinically
diagnosed IAH), comparing against validated measures of IAH. Despite high response rates, the sample size fell slightly short of the ideal (four to five respondents per item) but was more than adequate, according to Kline's criteria of a respondent to item ratio of 2:1 and a minimum of 100 participants [13] .
Some might regard self-reported hypoglycaemic events rather than objective blinded continuous glucose monitoring as a potential limitation of the study; however, the latter does not enable data collection over a long period of time in a large number of people or provide a clear assessment of event severity without a parallel diary, and is of limited use for diagnosing IAH [16] . Both studies are limited by the relative homogeneity of the samples (middle-aged white people with long-standing Type 1 diabetes). Use of this questionnaire in other populations (e.g. other cultural backgrounds, insulintreated Type 2 diabetes) is now required to confirm and expand upon these findings, and prospective studies are warranted to demonstrate test-retest reliability, responsiveness and predictive validity.
Overall, the HypoA-Q is likely to enable a more definitive diagnosis of IAH, and comprehensive characterization of those with problematic hypoglycaemia who are at high risk of SH and nocturnal hypoglycaemic events. This will enable improved classification of the spectrum of hypoglycaemia awareness in clinical practice, including evaluation of medical fitness, e.g. for activities such as driving.
The promising psychometric properties of the HypoA-Q suggest its potential value in clinical trials in which IAH is a primary or secondary endpoint.
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Access to the HypoA-Q
The HypoA-Q is available free of charge to clinicians, academic researchers and students for use in clinical practice or non-commercially funded research. Please contact Prof Jane Speight (jane.speight@ahpresearch.com or jane.speight@deakin.edu.au) to enquire about whether the version published here has been superseded and to request the latest version and scoring guidance. For commercially funded studies (whether initiated or sponsored by industry), a licence fee will apply and potential users should contact Prof. Speight for details.
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Supporting information
Additional Supporting Information may be found in the online version of this article:
Appendix S1. Design and debriefing of the Hypoglycaemia Awareness Questionnaire.
Appendix S2. The Hypoglycaemia Awareness Questionnaire. 
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This article is protected by copyright. All rights reserved. *At least one severe hypoglycaemic event in the past 6 months, assessed using HypoA-Q item 2a; † At least one hypoglycaemic event when asleep, assessed using HypoA-Q item 15.
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